(Allergan plc)

	AGN latest price $141.5500 (1.37%) ($138.5100 - $142.0100) on Thu. Apr. 25, 2019.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.89% (three month average)
RSI	32
Latest Price	$141.5500(1.37%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.2% a day on average for past five trading days.
Weekly Trend	AGN declines -2.6% a week on average for past two weeks.
Market Behavior	Rotation from value to growth for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(49%)    XLV(48%)    ARKG(47%)    XBI(47%)    DIA(45%)
Factors Impacting AGN price	AGN will decline at least -0.945% in a week (0% probabilities).   VIXM(-25%)    UUP(-25%)    TLT(-23%)    IFRA(-17%)    VXX(-15%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.945% (StdDev 1.89%)
Hourly BBV	0 ()
Intraday Trend	1.7%

1 - 5 Day Possible Target	$137.33(-2.98%)
Resistance Level	$144.78
5 Day Moving Average	$140.8(0.53%)
10 Day Moving Average	$142.2(-0.46%)
20 Day Moving Average	$144.78(-2.23%)
To recent high	-11.4%
To recent low	7.7%
Market Cap	$46.669b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed